Boston naming test in Alzheimer's disease

Salience network and parahippocampal dopamine dysfunction in memory‐impaired Parkinson disease

“…The LEDD is based on theoretical equivalence to Ldopa using the following formula: L-dopa dose + L-dopa dose x 1/3 if on entacapone + bromocriptine (mg) x 10 + cabergoline or pramipexole (mg) x 67 + ropinirole (mg) x 20 + pergolide (mg) x 100 + apomorphine (mg) x 8 21 . All participants received a neuropsychological assessment on medication to assess cognitive status and healthy controls showed no evidence of cognitive impairment ( Test, total score (language) 35 . All raw scores were converted into z-scores.…”

Impact of Mild Cognitive Impairment on Health-Related Quality of Life in Parkinson's Disease

“…One test per domain was designated as a core test, which was chosen based on relative independence from other core tests or other tests considered under the same domain: memory (California Verbal Learning Test II - Long Delay Free Recall) [22], attention [Wechsler Memory Scale (WMS) III Digit Span - Longest Span Forward] [23], executive function - working memory (WMS-III Letter-Number Sequencing) [23], executive function - cognitive flexibility (Visual Verbal Test - Total Number of Shifts) [24], executive function - inhibitory control [Delis-Kaplan Executive Function System (DKEFS) Color-Word Interference (CWI) - Time to Complete Condition 3] [25], processing speed (DKEFS CWI - Time to Complete Condition 1) [25], visuospatial function (Judgement of Line Orientation) [26], and language (DKEFS Verbal Fluency - Category Fluency Condition) [25]. Other tests were designated as non-core: memory [Rey Complex Figure Test and Recognition Trial (RCFT) - Delayed Recall [27], Modified Conditional Associative Learning Test - number of trials [28], RCFT - Recognition [27], California Verbal Learning Test - Total Free Recall Intrusions [21]], attention (WMS-III - Digit Span Total [23]), processing speed (Trails A [29], DKEFS CWI - Condition 2 Word Reading [25]), visuospatial function (RCFT - Copy [27]), language (30-item Boston Naming Test [30]), and executive function (DKEFS CWI Condition 3 - Total Errors [25], Modified Conditional Associative Learning Test - Number of Errors [28], WMS-III Digit Span - Longest Span Backward [23], California Verbal Learning Test-2 - Total Repetitions, i.e. errors [22], Trails B-A [29], DKEFS Verbal Fluency - Category Switch Total Switching Accuracy [25], CWI Condition 4 - Inhibition/Switching, in seconds [25], CWI Condition 4 - Inhibition/Switching Total Errors [25], DKEFS Letter Fluency - Total Correct [23], RCFT - Copy Q Score [27], California Verbal Learning Test-2 - Semantic Clustering [21], Visual Verbal Test - Total Correct [24]).…”

An examination of the Boston Naming Test: calculation of “estimated” 60-item score from 30- and 15-item scores in a cognitively impaired population

“…The Boston Naming Test (BNT) (Kaplan et al, 1983), an instrument that assesses confrontation naming, is useful in detecting word-retrieval problems and is one of the most frequently used instruments in evaluations of patients with known or suspected AD (Williams et al, 1989). Originally, the BNT was comprised of 85-items, but was reduced to the current 60-item test (Kaplan et al, 1976(Kaplan et al, , 1982Borod et al, 1980).…”